- A new NIH-led study in Annals of Internal Medicine reveals colonoscopy costs make up 55% of the $43.2 billion spent on U.S. cancer screenings in 2021. Key points include:
- Colorectal cancer screening is highly effective and has a Grade A recommendation.
- High upfront costs of colonoscopies can lead to significant downstream savings.
- Total screening costs, including follow-up procedures for other tests, must be considered.
AGA’s take: New Annals study digs into cost of colonoscopy (AGA)
0